Foghorn Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Foghorn Therapeutics Inc
TickerFHTX
CIK #0001822462
CUSIP344174107
SectorLife Sciences - Pharmaceutical Preparations
Address500 Technology Square Suite 700, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2024
[0001822462] 10-K
[0001822462] 10-Q
[0001822462] 3
[0001822462] 4
[0001822462] 8-K
[0001822462] SC 13D
[0001822462] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Eli Lilly & Co Foghorn Therapeutics Inc [2021-12-13] 0.7
Kadoch Cigall Foghorn Therapeutics Inc [2021-04-19] 11.05
FMR LLC Foghorn Therapeutics Inc [2021-02-08] 0.0
Klarman Family Foundation Foghorn Therapeutics Inc [2021-02-04] 5.97
Flagship Ventures Fund V LP Foghorn Therapeutics Inc [2020-10-29] 26.1
Form 3/4/5 Filer 2011 - 2024
Foghorn Therapeutics Inc.
Gottschalk Adrian
Cavalie Fanny
Bellon Steven F.
Costa Carlos
LaCascia Michael
Reine Allan
Agresta Samuel
Lynch Thomas J. Jr.
Gill Simba
Kadoch Cigall
Parshall B Lynne
Biller Scott
Mendelsohn Michael
Cole Douglas G.
Smith Ian F
Koppel Adam
Decicco Carl
Flagship Pioneering Inc.
Flagship Ventures Fund V, L.P.
Flagship Pioneering Special Opportunities Fund II General Pa
Flagship Ventures Opportunities Fund I General Partner LLC
Flagship Ventures Opportunities Fund I, L.P.
Afeyan Noubar
Flagship Ventures Fund V General Partner LLC
Flagship Pioneering Special Opportunities Fund II, L.P.
Abu Dhabi Investment Authority
Platinum Falcon B 2018 RSC Ltd
Platinum International Investment Holding RSC Ltd
Baselga Jose
Form 13F Holdings
Firm Period DFND Voting Shares
Flagship Pioneering Inc [2023-03-31] DFND 0.0 12,674,120.0
FMR LLC [2023-03-31] DFND 3,014,271.0 3,015,012.0
Artal Group S.A. [2023-03-31] DFND 1,720,720.0 1,720,720.0
Euclidean Capital LLC [2023-03-31] SOLE 1,261,261.0 1,261,261.0
BlackRock Inc. [2023-03-31] SOLE 1,223,927.0 1,242,520.0
Raymond James & Associates [2023-03-31] SOLE 0.0 1,078,056.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 984,935.0
Deerfield Management Company LP Series C [2023-03-31] DFND 777,525.0 777,525.0
Alphabet Inc. [2023-03-31] DFND 0.0 500,901.0
State Street Corp [2023-03-31] DFND 385,791.0 409,513.0
Geode Capital Management LLC [2023-03-31] DFND 386,008.0 386,008.0
Driehaus Capital Management LLC [2023-03-31] SOLE 343,720.0 343,720.0
Birchview Capital LP [2023-03-31] SOLE 264,843.0 264,843.0
Northern Trust Corp [2023-03-31] DFND 4,877.0 186,075.0
Citadel Advisors LLC [2023-03-31] DFND 156,372.0 156,372.0
Affinity Asset Advisors LLC [2023-03-31] SOLE 136,771.0 136,771.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 130,847.0 130,847.0
Morgan Stanley [2023-03-31] DFND 18,229.0 93,567.0
Bank of New York Mellon Corp [2023-03-31] DFND 68,271.0 71,032.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 54,929.0 54,929.0
Nuveen Asset Management LLC [2023-03-31] DFND 53,480.0 53,480.0
Baker Bros Advisors LP [2023-03-31] SOLE 45,027.0 45,027.0
Millennium Management LLC [2023-03-31] SOLE 37,885.0 37,885.0
Vanguard Group Inc [2023-03-31] DFND 0.0 37,030.0
Man Group plc [2023-03-31] DFND 33,977.0 33,977.0
Goldman Sachs Group Inc [2023-03-31] DFND 31,065.0 31,075.0
Russell Investments Group, Ltd. [2023-03-31] DFND 0.0 30,017.0
Acadian Asset Management LLC [2023-03-31] DFND 27,085.0 27,085.0
Cornercap Investment Counsel Inc [2023-03-31] SOLE 17,722.0 26,163.0
RhumbLine Advisers [2023-03-31] SOLE 9,805.0 25,314.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com